Spectral Diagnostics to Present at BioFinance 2012
News May 21, 2012
Spectral Diagnostics Inc., has announced that Dr. Paul Walker, the Company's President and Chief Executive Officer, will present at BioFinance 2012 on Wednesday, May 30, at 9:20 a.m. Eastern Time.
The conference will be held at the St. Andrew's Club & Conference Centre in Toronto, Ontario.
Dr. Walker will provide a corporate update, including information about the Company's pivotal sepsis program.
BioFinance is a prominent Canadian investor conference for the life sciences industry.
The two-day event brings together key industry players interested in investment opportunities and issues affecting companies in the life sciences sector.
Presenting companies span a range of industries including biologics, medical devices, drug delivery, vaccines, and diagnostics.
Evolution Threatens Efficient Bioproduction Scale-UpNews
The transition towards sustainable biobased chemical production is important for green growth, but productivity and yield of engineered cells frequently decrease in large industry-scale fermentation. According to a new study, the role of evolution has been underestimated in limiting bioprocesses.
Shire, Microsoft and EURORDIS Form Global Commission to Accelerate Rare Disease DiagnosisNews
The alliance aims to shorten the often multi-year journey that patients and families endure before being diagnosed with a rare disease.READ MORE
Studying Ebola-Host Cell Interaction Helps Find Targets for Antiviral DrugsNews
In some ways, the Ebola virus operates like a vampire; only after it is politely invited in to a host cell does it take up the task of destroying everything in its path. In a new study researchers seek to elucidate quantitatively the biomechanical mechanism of Ebola-host cell interaction, providing potential new targets for antiviral drug development.READ MORE